Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:32575983

Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis.

Simone Serrao · Davide Firinu · Alessandra Olianas · Margherita Deidda · Cristina Contini · Federica Iavarone · M Teresa Sanna · Mozhgan Boroumand · Francisco Amado · Massimo Castagnola · Irene Messana · Stefano Del Giacco · Barbara Manconi · Tiziana Cabras

Journal of proteome research · 2020 doi:10.1021/acs.jproteome.0c00207

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:32575983
kind
science-record
content_hash
sha256:438dbf556eb58ddad2607e20bf1822920fc94ae44ed4a6f4471de0cf13db0956
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:04Z
updated_at
2026-11-01T21:23:23Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis.
doi
10.1021/acs.jproteome.0c00207
pmid
32575983
authors array · 14 items
[0]
Simone Serrao
[1]
Davide Firinu
[2]
Alessandra Olianas
[3]
Margherita Deidda
[4]
Cristina Contini
[5]
Federica Iavarone
[6]
M Teresa Sanna
[7]
Mozhgan Boroumand
[8]
Francisco Amado
[9]
Massimo Castagnola
[10]
Irene Messana
[11]
Stefano Del Giacco
[12]
Barbara Manconi
[13]
Tiziana Cabras
journal
Journal of proteome research
year
2020
abstract
Mastocytosis is a myeloproliferative neoplasm causing abnormal clonal mast cell accumulation in different tissues, such as skin and bone marrow. A cutaneous subtype (CM) is distinguished from a systemic one (SM); SM patients can be grouped into SM with (SM+C) or without (SM-C) additional cutaneous lesions, and their classification is often challenging. This study was purposed to highlight variations in the salivary proteome of patients with different mastocytosis subtypes and compared to healthy controls. A top-down proteomics approach coupled to a label-free quantitation revealed salivary profiles in patients different from those of controls and a down-regulation of peptides/proteins involved in the mouth homeostasis and defense, such as statherin, histatins, and acidic proline-rich proteins (aPRPs), and in innate immunity and inflammation, such as the cathepsin inhibitors, suggesting a systemic condition associated with an exacerbated inflammatory state. The up-regulation of antileukoproteinase and S100A8 suggested a protective role against the disease status. The two SM forms were distinguished by the lower levels of truncated forms of aPRPs, statherin, P-B peptide, and cystatin D and the higher levels of thymosin β4 and α-defensins 1 and 4 in SM-C patients with respect to SM+C. Data are available via ProteomeXchange with identifier PXD017759.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous). Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05.
kind
methodological
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:32575983
locator
sections[7] "Statistical Analysis" paragraph 2
quote
The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous).
[1] object · 3 fields
asset
source:pmid:32575983
locator
sections[7] "Statistical Analysis" paragraph 2
quote
Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Data are available via ProteomeXchange with identifier PXD017759.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32575983
locator
sections[0] "Abstract" paragraph 1
quote
Data are available via ProteomeXchange with identifier PXD017759.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:32575983
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD017759
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD017759
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 6 items
[0] object · 15 fields
id
source:pmid:32575983
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1021/acs.jproteome.0c00207
sha256
sha256:72e12edaac849af29f80266955cac6a210b4213d4d81ab535c34754f68bc0dce
bytes
53660
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1021/acs.jproteome.0c00207
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8008451
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD017759
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD017759
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD017759
version
null
note
Data are available via ProteomeXchange with identifier PXD017759.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Data are available via ProteomeXchange with identifier PXD017759.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
HPLC-ESI-MS PROFILE OF SALIVARY PROTEINS IN MASTOCYTOSIS PATIENTS
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:32575983:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:d041aef4ac5c36bddc1467eca0453d9cb19f50476c535cd8f54100442c4e1835
bytes
2258
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[4]/table-wrap[1]#tbl1
version
null
note
Age/Gender, Diagnosis, Presence (Y) or Absence (N) of Aphtosis and/or Gastrointestinal (GI) Symptoms, Tryptase Serum Level, and Eventual Mutation of c-Kit Genes of each Patient at the Time of the Study
structure object · 5 fields
pmcid
PMC8008451
section_index
4
section_title
Study Subjects and Controls and Clinical Data
row_count
42
column_count
8
table object · 8 fields
label
Table 1
caption
Age/Gender, Diagnosis, Presence (Y) or Absence (N) of Aphtosis and/or Gastrointestinal (GI) Symptoms, Tryptase Serum Level, and Eventual Mutation of c-Kit Genes of each Patient at the Time of the Study
rows array · 42 items
[0] array · 8 items
[0]
patient
[1]
age/gender
[2]
diagnosis
[3]
secondary cutaneous symptoms
[4]
aphtosis
[5]
GI
[6]
tryptase (μg/L)
[7]
mutation(s)
[1] array · 8 items
[0]
#2
[1]
59/F
[2]
SM
[3]
[4]
N
[5]
Y
[6]
17.5
[7]
[2] array · 8 items
[0]
#5
[1]
54/F
[2]
SM
[3]
[4]
N
[5]
Y
[6]
16.5
[7]
[3] array · 8 items
[0]
#6
[1]
72/F
[2]
SM
[3]
[4]
N
[5]
Y
[6]
41.0
[7]
[4] array · 8 items
[0]
#9
[1]
45/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
33.6
[7]
M541L
[5] array · 8 items
[0]
#10
[1]
44/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
16.2
[7]
[6] array · 8 items
[0]
#11
[1]
58/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
20.2
[7]
D816V
[7] array · 8 items
[0]
#12
[1]
53/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
5.5
[7]
D816V/M541L
[8] array · 8 items
[0]
#13
[1]
35/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
44.7
[7]
[9] array · 8 items
[0]
#14
[1]
22/F
[2]
CM
[3]
[4]
N
[5]
N
[6]
5.0
[7]
[10] array · 8 items
[0]
#15
[1]
38/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
7.7
[7]
D816V
[11] array · 8 items
[0]
#16
[1]
52/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
37.5
[7]
D816V
[12] array · 8 items
[0]
#17
[1]
46/F
[2]
CM
[3]
[4]
Y
[5]
Y
[6]
4.5
[7]
[13] array · 8 items
[0]
#18
[1]
55/M
[2]
SM
[3]
[4]
Y
[5]
Y
[6]
27.1
[7]
D816V
[14] array · 8 items
[0]
#19
[1]
48/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
16.2
[7]
[15] array · 8 items
[0]
#20
[1]
32/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
53.5
[7]
D816V
[16] array · 8 items
[0]
#21
[1]
44/F
[2]
SM
[3]
[4]
N
[5]
N
[6]
16.0
[7]
[17] array · 8 items
[0]
#22
[1]
60/F
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
23.6
[7]
[18] array · 8 items
[0]
#23
[1]
62/F
[2]
SM
[3]
[4]
N
[5]
N
[6]
80.4
[7]
D816V
[19] array · 8 items
[0]
#24
[1]
49/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
29.1
[7]
D816V
[20] array · 8 items
[0]
#25
[1]
49/F
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
37.4
[7]
[21] array · 8 items
[0]
#26
[1]
35/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
16.5
[7]
[22] array · 8 items
[0]
#27
[1]
67/F
[2]
CM
[3]
[4]
N
[5]
N
[6]
7.2
[7]
[23] array · 8 items
[0]
#28
[1]
38/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
26.2
[7]
D816V
[24] array · 8 items
[0]
#29
[1]
57/M
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
77.4
[7]
D816V
[25] array · 8 items
[0]
#30
[1]
32/M
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
40.8
[7]
D816V
[26] array · 8 items
[0]
#31
[1]
39/M
[2]
CM
[3]
[4]
Y
[5]
Y
[6]
8.8
[7]
[27] array · 8 items
[0]
#35
[1]
34/M
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
28.7
[7]
[28] array · 8 items
[0]
#36
[1]
52/F
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
16.1
[7]
D816V
[29] array · 8 items
[0]
#37
[1]
28/F
[2]
CM
[3]
[4]
N
[5]
N
[6]
7.7
[7]
[30] array · 8 items
[0]
#43
[1]
71/F
[2]
SM
[3]
[4]
N
[5]
N
[6]
9.7
[7]
[31] array · 8 items
[0]
#45
[1]
23/M
[2]
CM
[3]
[4]
N
[5]
N
[6]
4.3
[7]
[32] array · 8 items
[0]
#46
[1]
75/F
[2]
SM
[3]
[4]
N
[5]
N
[6]
18.2
[7]
[33] array · 8 items
[0]
#47
[1]
46/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
7.3
[7]
[34] array · 8 items
[0]
#51
[1]
29/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
64.5
[7]
[35] array · 8 items
[0]
#52
[1]
44/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
7.41
[7]
D816V
[36] array · 8 items
[0]
#58
[1]
38/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
26.3
[7]
[37] array · 8 items
[0]
#59
[1]
67/F
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
30.6
[7]
[38] array · 8 items
[0]
#60
[1]
49/F
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
15.8
[7]
D816V
[39] array · 8 items
[0]
#63
[1]
56/M
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
60.8
[7]
D816V
[40] array · 8 items
[0]
#64
[1]
24/M
[2]
SM
[3]
Y
[4]
Y
[5]
Y
[6]
11.4
[7]
D816V
[41] array · 8 items
[0]
#66
[1]
36/F
[2]
SM
[3]
Y
[4]
N
[5]
Y
[6]
6.6
[7]
D816V
locator
section[4]/table-wrap[1]#tbl1
[3] object · 16 fields
id
asset:table:pmid:32575983:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:7cf7cebad78ccb7a0832cb07abdd0ce9f2eae73cad59748719bad2c60bd423e8
bytes
11835
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[6]/table-wrap[1]#tbl2
version
null
note
UniProt-KB Code, Experimental and Theoretical Average Mass Values ± Standard Deviations (SD), Average (Mav) and Monoisotopic ([M + H]+), Elution Times of Proteins and Peptides Analyzed, and Their PTMsb
structure object · 5 fields
pmcid
PMC8008451
section_index
6
section_title
RP-HPLC-Low-Resolution ESI-MS Analysis
row_count
64
column_count
7
table object · 8 fields
label
Table 2
caption
UniProt-KB Code, Experimental and Theoretical Average Mass Values ± Standard Deviations (SD), Average (Mav) and Monoisotopic ([M + H]+), Elution Times of Proteins and Peptides Analyzed, and Their PTMsb
rows array · 64 items
[0] array · 7 items
[0]
proteins/peptides
[1]
el. time (min ± 0.5)
[2]
Mav ± SD exper. (theor)
[3]
m/z (charge) for XIC search
[4]
[M + H]+ ± SD exper. (theor)
[5]
PTMs
[6]
m/z (charge) for MS/MS
[1] array · 1 item
[0]
Acid proline-rich proteins (PRP-1 and PRP-3 types)a
[2] array · 7 items
[0]
PRP-1 (P02810)
[1]
22.2
[2]
15515 ± 2 (15514–15,515)
[3]
1293.9(+12), 1194.4(+13), 1035.3(+15), 970.7(+16), 913.6(+17)
[4]
15506.1 ± 0.1 (15506.24–15507.22)
[5]
Q1 pyroglutamination, S8 and S22 phosphorylation
[6]
1293.68(+12); 1194(+13); 1035.28 (+15); 970.58 (+16); 862.85(+18)
[3] array · 7 items
[0]
PRP-1 1P
[1]
22.9
[2]
15435 ± 2 (15434–15,435)
[3]
1287.2(+12), 1188.3(+13), 1030.0(+15), 965.7(+16), 908.9(+17)
[4]
15426.1 ± 0.1 (15426.27–15427.26)
[5]
Q1 pyroglutamination, S8 or S22 phosphorylation
[6]
1287.01(+12); 1188.3(+13); 1030.0 (+15)
[4] array · 7 items
[0]
PRP-1 0P
[1]
23.2
[2]
15355 ± 2 (15354–15,355)
[3]
1280.5(+12), 1182.1(+13), 1024.6(+15), 960.7(+16), 904.2(+17)
[4]
15346.1 ± 0.1 (15346.31–15347.29)
[5]
Q1 pyroglutamination
[6]
1534.42 (+10); 904.08 (+17)
[5] array · 7 items
[0]
PRP-1 3P
[1]
21.6
[2]
15595 ± 2 (15594–15,595)
[3]
1418.7(+11), 1300.5(+12), 1200.6(+13), 1040.6(+15), 975.7(+16)
[4]
15585.8 ± 0.1 (15586.21–15587.19)
[5]
Q1 pyroglutamination, S8, S17, and S22 phosphorylation
[6]
1733.70 (+9); 1560.08 (+10); 1114.61 (+14); 975.56 (+16)
[6] array · 7 items
[0]
PRP-3 (P02810)
[1]
22.8
[2]
11161 ± 1 (11161–11,162)
[3]
1595.5(+7), 1396.2(+8), 1015.7(+11), 931.1(+12), 859.6(+13)
[4]
11155.01 ± 0.07 (11156.08–11157.06)
[5]
Q1 pyroglutamination, S8 and S22 phosphorylation
[6]
931.09(+12); 798.07(+14); 745.00(+15)
[7] array · 7 items
[0]
PRP-3 1P
[1]
23.4
[2]
11081 ± 1 (11081–11,082)
[3]
1584.1(+7), 1386.2(+8), 1008.4(+11), 924.5(+12), 853.4(+13)
[4]
11075.98 ± 0.07 (11076.11–11077.09)
[5]
Q1 pyroglutamination, S8 or S22 monophosphorylation
[6]
1386.13(+8); 1008.28(+11); 853.31(+13)
[8] array · 7 items
[0]
PRP-3 0P
[1]
23.8
[2]
11001 ± 1 (11001–11,002)
[3]
1376.2(+8), 1101.2(+10), 917.8(+12) 786.8(+14)
[4]
10996.01 ± 0.07 (10996.14–10997.13)
[5]
Q1 pyroglutamination
[6]
1001.10(+11); 786.72(+14)
[9] array · 7 items
[0]
PRP-3 desR6
[1]
22.8
[2]
11004 ± 1 (11005–11,006)
[3]
1573.2(+7), 1223.8(+9), 1001.5(+11), 847.6(+13)
[4]
10999.85 ± 0.07 (10999.97–11000.96)
[5]
C-term. R106 removal from PRP-3
[6]
1001.45(+11); 918.08(+12)
[10] array · 7 items
[0]
P-C peptide (P02810)
[1]
15.0
[2]
4370.9 ± 0.4 (4370.8)
[3]
1457.9(+3), 1093.7(+4)
[4]
4369.19 ± 0.03 (4369.20)
[5]
[6]
1457.07(+3); 1093.05(+4); 874.64(+5); 729.04(+6)
[11] array · 1 item
[0]
Statherin
[12] array · 7 items
[0]
statherin (P02808)
[1]
29.2
[2]
5380.0 ± 0.5 (5379.7)
[3]
1794.2(+3), 1345.9(+4), 1076.9(+5)
[4]
5377.46 ± 0.03 (5377.45)
[5]
S2 and S3 phosphorylation
[6]
1793.17(+3); 1345.12(+4); 1076.30(+5)
[13] array · 7 items
[0]
statherin 1P
[1]
28.9
[2]
5299.9 ± 0.5 (5299.7)
[3]
1767.6(+3), 1325.9(+4), 1060.9(+5)
[4]
5297.46 ± 0.03 (5297.48)
[5]
S2 or S3 phosphorylation
[6]
1325.12(+4); 1060.30(+5)
[14] array · 7 items
[0]
statherin des-F43
[1]
27.8
[2]
5232.4 ± 0.5 (5232.5)
[3]
1745.1(+3), 1309.1(+4), 1047.5(+5)
[4]
5230.39 ± 0.03 (5230.38)
[5]
C-term. F43 removal from statherin
[6]
1744.13(+3); 1308.35(+4); 1046.88(+5)
[15] array · 7 items
[0]
statherin desT42-F43
[1]
27.9
[2]
5131.2 ± 0.5 (5131.4)
[3]
1711.4(+3), 1283.8(+4), 1027.2(+5)
[4]
5129.34 ± 0.03 (5129.33)
[5]
C-term. T42 and F43 removal from statherin
[6]
1710.45(+3); 1283.09(+4); 1026.67(+5)
[16] array · 7 items
[0]
statherin desD1
[1]
28.7
[2]
5264.7 ± 0.5 (5264.6)
[3]
1755.9(+3), 1317.2(+4), 1053.9(+5)
[4]
5262.43 ± 0.03 (5262.42)
[5]
N-term D1 removal from statherin
[6]
1754.81(+3); 1316.36(+4); 1053.29(+5)
[17] array · 7 items
[0]
statherin des1-9
[1]
28.5
[2]
4127.9 ± 0.4 (4127.6)
[3]
1376.9(+3), 1032.9(+4)
[4]
4126.00 ± 0.02 (4125.99)
[5]
removal of D1SSEEKFLR9 from statherin
[6]
1376.00(+3); 1032.25(+4)
[18] array · 7 items
[0]
statherin des1-10
[1]
28.0
[2]
3971.3 ± 0.4 (3971.4)
[3]
1986.7(+2), 1324.8(+3)
[4]
3969.88 ± 0.02 (3969.89)
[5]
Removal of D1SSEEKFLRR10 from statherin
[6]
1323.96(+3); 993.22(+4)
[19] array · 7 items
[0]
statherin des1-13
[1]
27.5
[2]
3645.2 ± 0.4 (3645.0)
[3]
1823.6(+2), 1216.1(+3)
[4]
3643.69 ± 0.02 (3643.68)
[5]
Removal of D1SSEEKFLRRIGR13 from statherin
[6]
1215.23(+3); 911.68(+4)
[20] array · 1 item
[0]
P-B peptide
[21] array · 7 items
[0]
P-B peptide (P02814)
[1]
30.0
[2]
5792.9 ± 0.5 (5792.7)
[3]
1932.0(+3), 1449.2(+4), 1159.6(+5)
[4]
5790.05 ± 0.04 (5790.04)
[5]
[6]
1930.68(+3); 1448.27(+4); 1158.82(+5)
[22] array · 7 items
[0]
P-B des1-4
[1]
30.0
[2]
5371.0 ± 0.5 (5371.3)
[3]
1791.4(+3), 1343.8(+4), 1075.3(+5)
[4]
5368.83 ± 0.03 (5368.82)
[5]
removal of Q1RGP4 from P-B
[6]
1790.25(+3); 1342.96(+4); 1074.57(+5)
[23] array · 7 items
[0]
P-B des1-5
[1]
30.3
[2]
5215.0 ± 0.5 (5215.1)
[3]
1739.4(+3), 1304.8(+4), 1044.0(+5)
[4]
5212.74 ± 0.03 (5212.73)
[5]
removal of Q1RGPR5 from P-B
[6]
1303.93(+4); 1043.35(+5)
[24] array · 7 items
[0]
P-B des1-7
[1]
30.1
[2]
5060.1 ± 0.5 (5060.9)
[3]
1688.0(+3), 1266.2(+4), 1013.2(+5)
[4]
5058.66 ± 0.03 (5058.65)
[5]
removal of Q1RGPRGP7 from P-B
[6]
1686.88(+3); 1265.42(+4); 1012.54(+5)
[25] array · 7 items
[0]
P-B des1-12
[1]
27.5
[2]
4549.0 ± 0.5 (4549.3)
[3]
1517.5(+3), 1138.3(+4)
[4]
4547.41 ± 0.02 (4547.41)
[5]
removal of Q1RGPRGPYPPGP12 from P-B
[6]
1137.61(+4)
[26] array · 1 item
[0]
Histatins
[27] array · 7 items
[0]
Hst-1 (P15515)
[1]
21.9
[2]
4928.2 ± 0.5 (4928.2)
[3]
1644.1(+3), 1233.5(+4)
[4]
4926.19 ± 0.03 (4926.20)
[5]
S2 phosphorylation
[6]
986.05(+5); 821.87(+6); 704.61(+7)
[28] array · 7 items
[0]
Hst-1 0P
[1]
22.0
[2]
4848.2 ± 0.5 (4848.2)
[3]
1617.4(+3), 1213.5(+4)
[4]
4846.24 ± 0.03 (4846.23)
[5]
[6]
970.05(+5)
[29] array · 7 items
[0]
Hst-3 (P15516)
[1]
17.7
[2]
4062.2 ± 0.4 (4062.4)
[3]
1355.1(+3), 1016.6(+4)
[4]
4060.97 ± 0.02 (4060.98)
[5]
[6]
1015.99(+4); 813.00(+5); 677.67(+6)
[30] array · 7 items
[0]
Hst-3 1/25
[1]
14.3
[2]
3192.4 ± 0.3 (3192.5)
[3]
1065.1(+3), 799.1(+4)
[4]
3191.63 ± 0.02 (3191.62)
[5]
removal of S26NYLYDN32 from Hst-3
[6]
400.09(+8); 456.95(+9)
[31] array · 7 items
[0]
Hst-3 1/24
[1]
14.6
[2]
3036.5 ± 0.3 (3036.3)
[3]
1013.2(+3), 760.1(+4)
[4]
3035.53 ± 0.02 (3035.52)
[5]
removal of S26NYLYD31 from Hst-3
[6]
608.11(+5); 506.93(+6); 434.65(+7)
[32] array · 1 item
[0]
Cystatins
[33] array · 7 items
[0]
cystatin A (P01040)
[1]
31.8
[2]
11005 ± 2 (11006.5)
[3]
1001.59(+11), 1101.59(+10), 1223.94(+9), 1376.81(+8), 1573.36(+7), 1835.42(+6)
[4]
11000.65 ± 0.07 (11000.67)
[5]
[6]
1376.83(+8); 847.74(+13); 787.19(+14); 734.85(+15);
[34] array · 7 items
[0]
cystatin A Nα-Ac
[1]
33
[2]
11047 ± 2 (11048.5)
[3]
1005.41(+11), 1105.85(+10), 1228.61(+9), 1382.06(+8), 1579.36(+7), 1842.42(+6)
[4]
11042.55 ± 0.07 (11042.68)
[5]
N-terminal acetylation
[6]
1381.79(+8); 789.98(+14)
[35] array · 7 items
[0]
cystatin B-SSG (P04080)
[1]
32.8
[2]
11486 ± 2 (11486.9)
[3]
1915.5(+6), 1642.0(+7), 1436.9(+8), 1277.3(+9), 1149.7(+10), 1045.3(+11)
[4]
11480.61 ± 0.07 (11480.68)
[5]
N-terminal acetylation, C3 glutathionylation
[6]
1436.72(+8); 1277.31(+9); 766.91(+15), 718.79(+16)
[36] array · 7 items
[0]
cystatin C (P01034)
[1]
35.1
[2]
13342 ± 2 (13343.1)
[3]
1483.57(+9), 1335.32(+10), 1214.02(+11), 1112.93(+12), 1027.40(+13)
[4]
13335.31 ± 0.08 (13335.58)
[5]
2 disulfide bridges
[6]
1112.81(+12); 890.50(+15)
[37] array · 7 items
[0]
cystatin C Mox
[1]
35.3
[2]
13358 ± 1 (13358.4)
[3]
1485.28(+9), 1336.85(+10), 1215.41(+11), 1114.21(+12), 1028.58(+13)
[4]
13351.60 ± 0.08 (13351.57)
[5]
M14 oxidation of cystatin C
[6]
1114.23(+12); 954.20(+14)
[38] array · 7 items
[0]
cystatin D-R26 des1-8 (P28325)
[1]
38.0
[2]
13163 ± 2 (13163.0)
[3]
1646.40 (+8), 1463.60 (+9), 1317.30 (+10), 1197.60 (+11), 1097.90 (+12), 1013.50 (+13)
[4]
13155.25 ± 0.08 (13155.48)
[5]
removal of G1SASAQSR8, 2 disulfide bridges
[6]
941.09(+14); 823.71(+16)
[39] array · 7 items
[0]
cystatin D-R26 des1-5
[1]
37.7
[2]
13517 ± 2 (13517.3)
[3]
1690.70(+8), 1502.90(+9), 1352.70 (+10), 1229.80 (+11), 1127.4 (+12), 1040.40 (+13)
[4]
13509.41 ± 0.08 (13509.65)
[5]
Q1 pyroglutamination after removal of G1SASA5, 2 disulfide bridges
[6]
1502.63(+9), 1040.87(+13) 966.48(+14); 845.72(+16)
[40] array · 7 items
[0]
cystatin S (P01036)
[1]
35.3
[2]
14186 ± 2 (14185)
[3]
1774.3(+8), 1577.2(+9), 1419.6(+10), 1290.6(+11), 1183.2(+12), 1092.2(+13), 1014.3(+14)
[4]
14176.61 ± 0.08 (14176.81)
[5]
2 disulfide bridges
[6]
946.58(+15); 835.22(+17)
[41] array · 7 items
[0]
cystatin S1
[1]
35.3
[2]
14266 ± 2 (14265)
[3]
1784.3(+8), 1586.1(+9), 1427.6(+10), 1297.9(+11), 1189.8(+12), 1098.4(+13), 1020.0(+14)
[4]
14256.66 ± 0.09 (14256.77)
[5]
S3 phosphorylation of cystatin S, 2 disulfide bridges
[6]
1098.37(+13); 1019.69(+14); 951.91(+15)
[42] array · 7 items
[0]
cystatin S1ox
[1]
35.3
[2]
14281 ± 2 (14280.7)
[3]
1786.40(+8), 1589.70 (+9), 1429.30 (+10), 1299.50 (+11), 1191.30 (+12), 1099.70 (+13)
[4]
14272.66 ± 0.09 (14272.77)
[5]
W23 oxidation of cystatin S1
[6]
1299.08(+11); 1099.36(+13); 894.67(+16)
[43] array · 7 items
[0]
cystatin S2
[1]
35.3
[2]
14346 ± 2 (14345)
[3]
1794.3(+8), 1595.0(+9), 1435.6(+10), 1305.2(+11), 1196.5(+12), 1104.5(+13), 1025.7(+14)
[4]
14336.58 ± 0.09 (14336.74)
[5]
S1 and S3 phosphorylation of cystatin S, 2 disulfide bridges
[6]
957.31(+15); 897.55(+16)
[44] array · 7 items
[0]
cystatin SN (P01037)
[1]
34.6
[2]
14312 ± 2 (14313)
[3]
1790.0(+8), 1591.2(+9), 1432.2(+10), 1302.1(+11), 1193.7(+12), 1101.9(+13), 1023.3(+14)
[4]
14304.03 ± 0.09 (14304.09)
[5]
2 disulfide bridges
[6]
1023.29(+14); 796.01(+18); 716.50(+20)
[45] array · 7 items
[0]
cystatin SNox
[1]
34.6
[2]
14328 ± 2 (14328)
[3]
1792.30(+8), 1593.20 (+9), 1434.00 (+10), 1303.30 (+11), 1195.20 (+12), 1103.30 (+13)
[4]
14320.09 ± 0.09 (14319.84)
[5]
2 disulfide bridges, W23 oxidation
[6]
843.64(+17); 754.26(+19); 717.35(+20); 682.52(+21)
[46] array · 7 items
[0]
cystatin SA (P09228)
[1]
36.8
[2]
14347 ± 2 (14346)
[3]
1794.4(+8), 1595.1(+9), 1435.7(+10), 1305.3(+11), 1196.6(+12), 1104.6(+13), 1025.8(+14)
[4]
14337.87 ± 0.09 (14338.01)
[5]
1 disulfide bridge
[6]
897.50(+16); 844.88(+17); 798.78(+18);
[47] array · 1 item
[0]
Antileukoproteinase
[48] array · 7 items
[0]
SLPI (P03973)
[1]
26.2
[2]
11709 ± 1 (11710)
[3]
1952.64(+6), 1673.84(+7), 1464.73(+8), 1302.10(+9)
[4]
11702.41 ± 0.07 (11702.36)
[5]
8 disulfide bridges
[6]
1171.82(+10); 1065.47(+11); 976.69(+12); 837.45(+14)
[49] array · 1 item
[0]
α-Defensins
[50] array · 7 items
[0]
α-defensin 1 (P59665)
[1]
23.5
[2]
3442.5 ± 0.3 (3442.1)
[3]
1772.03(+2), 1148.36(+3), 861.52(+4)
[4]
3440.45 ± 0.02 (3440.519)
[5]
3 disulfide bridges
[6]
861.14(+4); 689.11(+5)
[51] array · 7 items
[0]
α-defensin 2 (P59665/6)
[1]
23.5
[2]
3370.7 ± 0.3 (3370.9)
[3]
1686.49(+2), 1124.66(+3), 843.75(+4)
[4]
3370.41 ± 0.02 (3370.484)
[5]
3 disulfide bridges
[6]
843.61(+4); 675.10(+5)
[52] array · 7 items
[0]
α-defensin 3 (P59666)
[1]
23.5
[2]
3485.8 ± 0.3 (3486.1)
[3]
1744.03(+2), 1163.03(+3), 872.52(+4)
[4]
3484.53 ± 0.02 (3484.509)
[5]
3 disulfide bridges
[6]
872.11(+4); 698.09(+5)
[53] array · 7 items
[0]
α-defensin 4 (P12838)
[1]
27.2
[2]
3709.1 ± 0.3 (3709.4)
[3]
1855.71(+2), 1237.48(+3), 928.36(+4)
[4]
3707.68 ± 0.02 (3707.767)
[5]
3 disulfide bridges
[6]
928.18(+4); 742.74(+5);
[54] array · 1 item
[0]
Thymosin β4
[55] array · 7 items
[0]
Tβ4 (P62328)
[1]
18.5
[2]
4963.7 ± 0.5 (4963.5)
[3]
1655.51(+3), 1241.88(+4), 993.71(+5)
[4]
4961.47 ± 0.03 (4961.494)
[5]
N-terminal acetylation
[6]
710.08(+7), 621.32(+8)
[56] array · 1 item
[0]
S100A proteins
[57] array · 7 items
[0]
S100A8 (P05109)
[1]
40.4
[2]
10834 ± 2 (10834.6)
[3]
1355.3(+8), 1204.8(+9), 1084.5(+10), 985.9(+11)
[4]
10827.41 ± 0.07 (10828.66)
[5]
[6]
903.62(+12); 834.11(+13); 774.75(+14)
[58] array · 7 items
[0]
S100A8 SNO
[1]
40.8
[2]
10863 ± 2 (10863.5)
[3]
1358.9(+8), 1208.1(+9), 1087.3(+10), 988.6(+11)
[4]
10857.37 ± 0.07 (10857.65)
[5]
C42 nitrosylation
[6]
1087.49(+10); 680.03(+16); 640.03(+17)
[59] array · 7 items
[0]
S100A8 hyperoxidized
[1]
39.3
[2]
10915 ± 2 (10914.6)
[3]
1365.3(+8), 1213.7(+9), 1092.5(+10), 993.2(+11)
[4]
10908.40 ± 0.07 (10908.63)
[5]
C42-SO3H, W54 dioxidation or C42-SO3H, W54, and M78 oxidation
[6]
993.20(+11); 910.37(+12); 683.16(+16); 642.85(+17)
[60] array · 7 items
[0]
S100A9(S) (P06702)
[1]
42.2
[2]
12690 ± 2 (12689.3)
[3]
1410.9(+9), 1269.9(+10), 1154.6(+11), 1058.4(+12), 977.1(+13)
[4]
12682.21 ± 0.08 (12682.29)
[5]
N-term. Acetylation after M1TCKM5 removal
[6]
1410.67(+9); 1269.93(+10); 977.22(+13); 793.95(+16); 747.48(+17); 705.85(+18);
[61] array · 7 items
[0]
S100A9(S) 1P
[1]
42.2
[2]
12770 ± 2 (12769.3)
[3]
1419.8(+9), 1277.9(+10), 1161.8(+11), 1065.1(+12), 983.3(+13)
[4]
12762.05 ± 0.08 (12762.26)
[5]
T108 phosphorylation of S100A9(S)
[6]
1161.66(+11); 798.96(+16); 710.29(+18)
[62] array · 7 items
[0]
S100A9(S)ox
[1]
41.3
[2]
12706 ± 2 (12705.3)
[3]
1412.7(+9), 1271.5(+10), 1156.0(+11), 1059.8(+12), 978.3(+13)
[4]
12698.14 ± 0.08 (12698.29)
[5]
M89, or 78 or 76 or 58 oxidation of S100A9(S)
[6]
1271.41(+10); 1155.92(+11); 908.51(+14)
[63] array · 7 items
[0]
S100A9(S)ox 1P
[1]
41.3
[2]
12786 ± 2 (12785.3)
[3]
1421.9(+9), 1279.5(+10), 1163.3(+11), 1066.4(+12), 984.5(+13)
[4]
12778.21 ± 0.08 (12778.25)
[5]
T108 phosphorylation of S100A9(S)ox
[6]
1419.82(+9); 983.26(+13); 913.10(+14)
locator
section[6]/table-wrap[1]#tbl2
[4] object · 16 fields
id
asset:table:pmid:32575983:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:abf58967b1d8178cc9fd9ab79bd07f8993cdb2d176bd48ae907ef9ecef227df1
bytes
5282
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[10]/table-wrap[1]#tbl3
version
null
note
XIC Peak Areas Values (Mean ± SD), Frequencies, and p Values Obtained by Statistical Analysis by Comparing the Three Patients’ Groups with Respect to the Controls and Each Othera
structure object · 5 fields
pmcid
PMC8008451
section_index
10
section_title
Quantitative Comparison between Controls and Patients
row_count
49
column_count
7
table object · 8 fields
label
Table 3
caption
XIC Peak Areas Values (Mean ± SD), Frequencies, and p Values Obtained by Statistical Analysis by Comparing the Three Patients’ Groups with Respect to the Controls and Each Othera
rows array · 49 items
[0] array · 4 items
[0]
[1]
[2]
XIC peak area ×108 (mean ± SD) and frequency
[3]
p values
[1] array · 7 items
[0]
no.
[1]
protein/peptide
[2]
CM
[3]
SM
[4]
Ctrls
[5]
CM vs Ctrls
[6]
SM vs Ctrls
[2] array · 7 items
[0]
#1
[1]
PRP-1
[2]
17.8 ± 10.1 (6/6)
[3]
27.4 ± 27.2 (35/35)
[4]
99.9 ± 70.9 (48/48)
[5]
<0.0001 ↓CM
[6]
< 0.0001 ↓SM
[3] array · 7 items
[0]
#2
[1]
PRP-1 1P
[2]
2.5 ± 3.1 (5/6)
[3]
3.7 ± 5.2 (29/35)
[4]
12.8 ± 12.9 (47/48)
[5]
0.002 ↓CM
[6]
< 0.0001 ↓SM
[4] array · 7 items
[0]
#3
[1]
PRP-1 0P
[2]
(0/6)
[3]
0.09 ± 0.3 (6/35)
[4]
0.5 ± 0.9 (22/48)
[5]
NA
[6]
0.003 ↓SM
[5] array · 7 items
[0]
#4
[1]
PRP-1 3P
[2]
0.2 ± 0.2 (4/6)
[3]
0.4 ± 0.6 (22/35)
[4]
2.0 ± 1.9 (44/48)
[5]
0.002 ↓CM
[6]
< 0.0001 ↓SM
[6] array · 7 items
[0]
#5
[1]
PRP-3
[2]
5.9 ± 4.4 (6/6)
[3]
9.5 ± 11.3 (33/35)
[4]
35.1 ± 29.3 (48/48)
[5]
0.0002 ↓CM
[6]
< 0.0001 ↓SM
[7] array · 7 items
[0]
#6
[1]
PRP-3 1P
[2]
1.1 ± 1.0 (6/6)
[3]
1.5 ± 1.8 (29/35)
[4]
4.9 ± 4.1 (47/48)
[5]
0.002 ↓CM
[6]
< 0.0001 ↓SM
[8] array · 7 items
[0]
#7
[1]
PRP-3 0P
[2]
(0/10)
[3]
0.004 ± 0.02 (2/35)
[4]
0.4 ± 1.1 (18/48)
[5]
NA
[6]
0.0003 ↓SM
[9] array · 7 items
[0]
#8
[1]
PRP-3 desR106
[2]
3.1 ± 2.7 (6/6)
[3]
2.8 ± 5.9 (26/35)
[4]
3.8 ± 6.2 (40/48)
[5]
•
[6]
•
[10] array · 7 items
[0]
#9
[1]
P-C peptide
[2]
4.1 ± 4.4 (6/6)
[3]
7.0 ± 10.0 (33/35)
[4]
20.4 ± 16.2 (48/48)
[5]
0.001 ↓CM
[6]
< 0.0001 ↓SM
[11] array · 7 items
[0]
#10
[1]
statherin
[2]
5.4 ± 6.6 (5/6)
[3]
6.0 ± 6.6 (34/35)
[4]
13.4 ± 10.1 (47/47)
[5]
0.02 ↓CM
[6]
0.0001 ↓SM
[12] array · 7 items
[0]
#11
[1]
Stath. 1P
[2]
0.2 ± 0.2 (3/6)
[3]
0.1 ± 0.2 (17/35)
[4]
0.3 ± 0.4 (32/47)
[5]
•
[6]
0.03 ↓SM
[13] array · 7 items
[0]
#12
[1]
Stath. des-F43
[2]
1.1 ± 1.0 (6/6)
[3]
1.0 ± 0.9 (34/35)
[4]
1.9 ± 1.8 (46/47)
[5]
•
[6]
0.006 ↓SM
[14] array · 7 items
[0]
#13
[1]
Stath. desT42-F43
[2]
0.7 ± 0.4 (6/6)
[3]
0.4 ± 0.4 (25/35)
[4]
0.7 ± 0.7 (46/47)
[5]
•
[6]
•
[15] array · 7 items
[0]
#14
[1]
Stath. desD1
[2]
0.7 ± 0.9 (5/6)
[3]
0.5 ± 0.5 (31/35)
[4]
0.8 ± 0.8 (46/47)
[5]
•
[6]
0.02 ↓SM
[16] array · 7 items
[0]
#15
[1]
Stath. des1-9
[2]
0.1 ± 0.2 (5/6)
[3]
0.2 ± 0.4 (18/35)
[4]
0.7 ± 0.7 (40/47)
[5]
•
[6]
< 0.0001 ↓SM
[17] array · 7 items
[0]
#16
[1]
Stath. des1-10
[2]
0.2 ± 0.2 (5/6)
[3]
0.3 ± 0.4 (24/35)
[4]
0.5 ± 0.5 (44/47)
[5]
•
[6]
0.001 ↓SM
[18] array · 7 items
[0]
#17
[1]
Stath. des1-13
[2]
0.1 ± 0.1 (4/6)
[3]
0.1 ± 0.2 (22/35)
[4]
0.3 ± 0.2 (45/47)
[5]
0.04 ↓CM
[6]
< 0.0001 ↓SM
[19] array · 7 items
[0]
#18
[1]
P-B peptide
[2]
7.6 ± 7.9 (6/6)
[3]
9.2 ± 7.8 (34/35)
[4]
21.9 ± 14.3 (47/47)
[5]
0.004 ↓CM
[6]
< 0.0001 ↓SM
[20] array · 7 items
[0]
#19
[1]
P-B des1-4
[2]
0.9 ± 0.6 (6/6)
[3]
1.0 ± 0.8 (31/35)
[4]
1.5 ± 1.7 (39/48)
[5]
•
[6]
•
[21] array · 7 items
[0]
#20
[1]
P-B des1-5
[2]
3.0 ± 3.6 (6/6)
[3]
1.8 ± 2.4 (30/35)
[4]
2.3 ± 2.8 (42/48)
[5]
•
[6]
•
[22] array · 7 items
[0]
#21
[1]
P-B des1-7
[2]
1.7 ± 0.9 (6/6)
[3]
1.7 ± 1.5 (32/35)
[4]
4.4 ± 2.8 (47/48)
[5]
0.007 ↓CM
[6]
< 0.0001 ↓SM
[23] array · 7 items
[0]
#22
[1]
P-B des1-12
[2]
0.8 ± 0.4 (6/6)
[3]
0.6 ± 0.6 (31/35)
[4]
1.0 ± 1.4 (46/48)
[5]
•
[6]
•
[24] array · 7 items
[0]
#23
[1]
Hst-1
[2]
1.1 ± 1.6 (4/6)
[3]
1.1 ± 1.5 (24/35)
[4]
2.9 ± 2.9 (34/48)
[5]
•
[6]
0.02 ↓SM
[25] array · 7 items
[0]
#24
[1]
Hst-1 0P
[2]
(0/6)
[3]
0.2 ± 0.3 (15/35)
[4]
0.4 ± 0.7 (23/48)
[5]
NA
[6]
•
[26] array · 7 items
[0]
#25
[1]
Hst-3
[2]
0.01 ± 0.03 (1/6)
[3]
0.3 ± 0.6 (12/35)
[4]
1.2 ± 1.7 (26/48)
[5]
NA
[6]
0.008 ↓SM
[27] array · 7 items
[0]
#26
[1]
Hst-3 1/25
[2]
(0/6)
[3]
0.04 ± 0.1 (6/35)
[4]
0.9 ± 1.2 (25/48)
[5]
NA
[6]
0.0001 ↓SM
[28] array · 7 items
[0]
#27
[1]
Hst-3 1/24
[2]
(0/6)
[3]
0.8 ± 1.7 (15/27)
[4]
3.0 ± 3.4 (40/48)
[5]
NA
[6]
< 0.0001 ↓SM
[29] array · 7 items
[0]
#28
[1]
Cyst. A
[2]
2.0 ± 1.4 (6/6)
[3]
1.2 ± 1.2 (35/35)
[4]
2.2 ± 1.9 (47/48)
[5]
•
[6]
0.001 ↓SM
[30] array · 7 items
[0]
#29
[1]
Cyst B (all proteoforms)
[2]
1.3 ± 1.1 (6/6)
[3]
1.2 ± 1.2 (34/35)
[4]
1.4 ± 1.3 (43/48)
[5]
•
[6]
•
[31] array · 7 items
[0]
#30
[1]
Cyst. C (all proteoforms)
[2]
0.03 ± 0.07 (1/6)
[3]
0.05 ± 0.2 (3/35)
[4]
0.6 ± 0.7 (32/48)
[5]
NA
[6]
< 0.0001 ↓SM
[32] array · 7 items
[0]
#31
[1]
Cyst. D-R26 des1-5
[2]
0.4 ± 0.9 (1/6)
[3]
0.5 ± 0.8 (19/35)
[4]
0.8 ± 1.1 (28/48)
[5]
NA
[6]
•
[33] array · 7 items
[0]
#32
[1]
Cyst. D-R26 des1-8
[2]
(0/6)
[3]
0.06 ± 0.1 (11/35)
[4]
0.1 ± 0.2 (15/48)
[5]
NA
[6]
•
[34] array · 7 items
[0]
#33
[1]
Cyst. S
[2]
(0/6)
[3]
0.3 ± 0.7 (11/35)
[4]
2.5 ± 0.5 (29/48)
[5]
NA
[6]
0.0007 ↓SM
[35] array · 7 items
[0]
#34
[1]
Cyst. S1 (all proteoforms)
[2]
11.3 ± 12.7 (6/6)
[3]
4.5 ± 3.8 (33/35)
[4]
10.3 ± 10.6 (45/48)
[5]
•
[6]
0.002 ↓SM
[36] array · 7 items
[0]
#35
[1]
Cyst. S2
[2]
1.9 ± 3.0 (2/6)
[3]
2.2 ± 3.6 (22/35)
[4]
3.8 ± 3.9 (45/48)
[5]
•
[6]
0.002 ↓SM
[37] array · 7 items
[0]
#36
[1]
Cyst. SN (all proteoforms)
[2]
10.2 ± 13.8 (4/6)
[3]
9.2 ± 11.1 (31/35)
[4]
20.7 ± 17.1 (47/48)
[5]
•
[6]
0.0005 ↓SM
[38] array · 7 items
[0]
#37
[1]
Cyst. SA
[2]
0.9 ± 1.9 (2/6)
[3]
0.8 ± 2.1 (9/35)
[4]
2.9 ± 3.8 (35/48)
[5]
•
[6]
<0.0001 ↓SM
[39] array · 7 items
[0]
#38
[1]
Tβ4
[2]
0.4 ± 0.3 (5/6)
[3]
0.4 ± 0.5 (24/35)
[4]
0.8 ± 1.0 (30/48)
[5]
•
[6]
•
[40] array · 7 items
[0]
#39
[1]
α-defensin 1
[2]
1.1 ± 0.7 (6/6)
[3]
1.4 ± 1.9 (33/35)
[4]
1.9 ± 2.9 (41/48)
[5]
•
[6]
•
[41] array · 7 items
[0]
#40
[1]
α-defensin 2
[2]
0.8 ± 0.6 (6/6)
[3]
0.7 ± 0.9 (31/35)
[4]
1.3 ± 1.7 (37/48)
[5]
•
[6]
•
[42] array · 7 items
[0]
#41
[1]
α-defensin 3
[2]
0.6 ± 0.7 (5/6)
[3]
0.3 ± 0.4 (21/35)
[4]
0.8 ± 1.3 (30/48)
[5]
•
[6]
•
[43] array · 7 items
[0]
#42
[1]
α-defensin 4
[2]
0.2 ± 0.1 (3/6)
[3]
0.1 ± 0.2 (15/35)
[4]
0.3 ± 0.4 (23/48)
[5]
•
[6]
•
[44] array · 7 items
[0]
#43
[1]
S100A9(S) + (S)ox
[2]
1.3 ± 1.5 (4/6)
[3]
1.5 ± 1.9 (24/35)
[4]
2.3 ± 2.7 (39/48)
[5]
•
[6]
•
[45] array · 7 items
[0]
#44
[1]
S100A9(S) 1P + (S)ox 1P
[2]
0.4 ± 0.5 (3/6)
[3]
0.6 ± 1.0 (16/35)
[4]
0.5 ± 1.0 (17/48)
[5]
•
[6]
•
[46] array · 7 items
[0]
#45
[1]
SLPI
[2]
0.2 ± 0.3 (3/6)
[3]
0.2 ± 0.8 (18/35)
[4]
0.1 ± 0.20 (10/48)
[5]
•
[6]
0.005 ↑SM
[47] array · 7 items
[0]
#46
[1]
S100A8 (all proteoforms)
[2]
0.5 ± 1.1 (1/6)
[3]
0.6 ± 1.1 (14/35)
[4]
0.2 ± 0.6 (9/48)
[5]
NA
[6]
0.02 ↑SM
[48] array · 7 items
[0]
#47
[1]
S100A8-SNO
[2]
0.5 ± 1.1 (1/6)
[3]
0.3 ± 0.7 (8/35)
[4]
0.1 ± 0.5 (6/48)
[5]
NA
[6]
•
locator
section[10]/table-wrap[1]#tbl3
[5] object · 16 fields
id
asset:table:pmid:32575983:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:a1905f171d1bc6d3b40026923a10bf24cb17ef2c110aed3852a417f46b60af36
bytes
1053
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#tbl4
version
null
note
Results of Correlation Analysis between Salivary Proteins/Peptides and Tryptase Levels in SM Patients and in the Subgroup SM-Ca
structure object · 5 fields
pmcid
PMC8008451
section_index
12
section_title
Correlation Analysis with Tryptase and with Oral Aphtosis and GI Symptoms
row_count
14
column_count
6
table object · 8 fields
label
Table 4
caption
Results of Correlation Analysis between Salivary Proteins/Peptides and Tryptase Levels in SM Patients and in the Subgroup SM-Ca
rows array · 14 items
[0] array · 4 items
[0]
[1]
SM (n = 35)
[2]
SM-C (n = 8)
[3]
[1] array · 6 items
[0]
protein/peptide
[1]
p value
[2]
R
[3]
p value
[4]
R
[5]
distinctive between SM-C and SM+C
[2] array · 6 items
[0]
PRP-1 1P
[1]
[2]
[3]
0.04 (+)
[4]
0.77
[5]
[3] array · 6 items
[0]
PRP-3 1P
[1]
[2]
[3]
0.03 (+)
[4]
0.77
[5]
[4] array · 6 items
[0]
PRP-3 desR106
[1]
[2]
[3]
0.007 (+)
[4]
0.88
[5]
Y (↑ in SM-C)
[5] array · 6 items
[0]
Statherin desD1
[1]
[2]
[3]
0.01 (+)
[4]
0.86
[5]
[6] array · 6 items
[0]
Statherin des1-10
[1]
0.03 (+)
[2]
0.40
[3]
0.02 (+)
[4]
0.79
[5]
[7] array · 6 items
[0]
Statherin des1-13
[1]
0.02 (+)
[2]
0.40
[3]
0.02 (+)
[4]
0.79
[5]
[8] array · 6 items
[0]
P-B des1-4
[1]
0.02 (+)
[2]
0.38
[3]
0.002 (+)
[4]
0.93
[5]
[9] array · 6 items
[0]
P-B des1-5
[1]
[2]
[3]
0.02 (+)
[4]
0.81
[5]
Y (↑ in SM-C)
[10] array · 6 items
[0]
P-B des1-7
[1]
[2]
[3]
0.01 (+)
[4]
0.86
[5]
[11] array · 6 items
[0]
P-B des1-12
[1]
[2]
[3]
0.006 (+)
[4]
0.89
[5]
[12] array · 6 items
[0]
Cystatin D-R26 des1-5
[1]
0.02 (+)
[2]
0.40
[3]
0.005 (+)
[4]
0.90
[5]
Y (↑ in SM-C)
[13] array · 6 items
[0]
Thymosin β4
[1]
[2]
[3]
0.005 (−)
[4]
–0.84
[5]
Y (↓ in SM-C)
locator
section[12]/table-wrap[1]#tbl4
gaps array · 2 items
[0]
asset:data:geo:PXD017759 not downloaded
[1]
asset:data:geo:PXD017759 licence not read
analysis object · 4 fields
state
complete
methods array · 1 item
[0] object · 10 fields
id
method-1
family
group_comparison
specific
welch_t_test
label
Group comparison
dsl_operations array · 1 item
[0]
welch_t
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
reordered
quote
The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous). Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05.
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
welch_t
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: welch_t_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD017759
resolved_accessions array · 1 item
[0]
PXD017759
statements array · 1 item
[0]
Data are available via ProteomeXchange with identifier PXD017759.
basis
The paper names PXD017759 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
welch_t
assets array · 6 items
[0]
source:pmid:32575983
[1]
data:geo:PXD017759
[2]
asset:table:pmid:32575983:1
[3]
asset:table:pmid:32575983:2
[4]
asset:table:pmid:32575983:3
[5]
asset:table:pmid:32575983:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD017759
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:20:34Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
44102
completion_tokens
1156
cached_tokens
784
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:32575983
type
paper
label
pmid:32575983
[1] object · 3 fields
id
source:pmid:32575983
type
manuscript
label
PMID 32575983 full text
[2] object · 3 fields
id
data:geo:PXD017759
type
dataset
label
GEO PXD017759
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:32575983
type
paper
label
pmid:32575983
[1] object · 3 fields
id
source:pmid:32575983
type
manuscript
label
PMID 32575983 full text
[2] object · 3 fields
id
data:geo:PXD017759
type
dataset
label
GEO PXD017759
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-32575983
type
extraction
used array · 1 item
[0]
source:pmid:32575983
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD017759
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD017759
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:32575983
parent_hash
sha256:a7019602b245c7fa0a5763f9973d9d96a4ac082d1a5a9398e9a5df412a9ca938
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:PXD017759 licence not read
[1]
asset:data:geo:PXD017759 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
welch_t
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous). Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32575983", "kind": "science-record", "revision": 6, "content_hash": "sha256:438dbf556eb58ddad2607e20bf1822920fc94ae44ed4a6f4471de0cf13db0956", "created_at": "2026-11-01T15:41:04Z", "updated_at": "2026-11-01T21:23:23Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis.", "doi": "10.1021/acs.jproteome.0c00207", "pmid": "32575983", "authors": ["Simone Serrao", "Davide Firinu", "Alessandra Olianas", "Margherita Deidda", "Cristina Contini", "Federica Iavarone", "M Teresa Sanna", "Mozhgan Boroumand", "Francisco Amado", "Massimo Castagnola", "Irene Messana", "Stefano Del Giacco", "Barbara Manconi", "Tiziana Cabras"], "journal": "Journal of proteome research", "year": 2020, "abstract": "Mastocytosis is a myeloproliferative neoplasm causing abnormal clonal mast cell accumulation in different tissues, such as skin and bone marrow. A cutaneous subtype (CM) is distinguished from a systemic one (SM); SM patients can be grouped into SM with (SM+C) or without (SM-C) additional cutaneous lesions, and their classification is often challenging. This study was purposed to highlight variations in the salivary proteome of patients with different mastocytosis subtypes and compared to healthy controls. A top-down proteomics approach coupled to a label-free quantitation revealed salivary profiles in patients different from those of controls and a down-regulation of peptides/proteins involved in the mouth homeostasis and defense, such as statherin, histatins, and acidic proline-rich proteins (aPRPs), and in innate immunity and inflammation, such as the cathepsin inhibitors, suggesting a systemic condition associated with an exacerbated inflammatory state. The up-regulation of antileukoproteinase and S100A8 suggested a protective role against the disease status. The two SM forms were distinguished by the lower levels of truncated forms of aPRPs, statherin, P-B peptide, and cystatin D and the higher levels of thymosin β4 and α-defensins 1 and 4 in SM-C patients with respect to SM+C. Data are available via ProteomeXchange with identifier PXD017759.", "claims": [{"id": "claim-method", "statement": "The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous). Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32575983", "locator": "sections[7] \"Statistical Analysis\" paragraph 2", "quote": "The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous)."}, {"asset": "source:pmid:32575983", "locator": "sections[7] \"Statistical Analysis\" paragraph 2", "quote": "Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Data are available via ProteomeXchange with identifier PXD017759.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32575983", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Data are available via ProteomeXchange with identifier PXD017759."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32575983"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD017759"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD017759"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32575983", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1021/acs.jproteome.0c00207", "sha256": "sha256:72e12edaac849af29f80266955cac6a210b4213d4d81ab535c34754f68bc0dce", "bytes": 53660, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1021/acs.jproteome.0c00207", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8008451", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD017759", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD017759", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD017759", "version": null, "note": "Data are available via ProteomeXchange with identifier PXD017759.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Data are available via ProteomeXchange with identifier PXD017759.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "HPLC-ESI-MS PROFILE OF SALIVARY PROTEINS IN MASTOCYTOSIS PATIENTS", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32575983:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:d041aef4ac5c36bddc1467eca0453d9cb19f50476c535cd8f54100442c4e1835", "bytes": 2258, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[1]#tbl1", "version": null, "note": "Age/Gender, Diagnosis, Presence (Y) or Absence (N) of Aphtosis and/or Gastrointestinal (GI) Symptoms, Tryptase Serum Level, and Eventual Mutation of c-Kit Genes of each Patient at the Time of the Study", "structure": {"pmcid": "PMC8008451", "section_index": 4, "section_title": "Study Subjects and Controls and Clinical Data", "row_count": 42, "column_count": 8}, "table": {"label": "Table 1", "caption": "Age/Gender, Diagnosis, Presence (Y) or Absence (N) of Aphtosis and/or Gastrointestinal (GI) Symptoms, Tryptase Serum Level, and Eventual Mutation of c-Kit Genes of each Patient at the Time of the Study", "rows": [["patient", "age/gender", "diagnosis", "secondary cutaneous symptoms", "aphtosis", "GI", "tryptase (μg/L)", "mutation(s)"], ["#2", "59/F", "SM", "", "N", "Y", "17.5", ""], ["#5", "54/F", "SM", "", "N", "Y", "16.5", ""], ["#6", "72/F", "SM", "", "N", "Y", "41.0", ""], ["#9", "45/M", "SM", "Y", "N", "Y", "33.6", "M541L"], ["#10", "44/F", "SM", "Y", "Y", "Y", "16.2", ""], ["#11", "58/F", "SM", "Y", "Y", "Y", "20.2", "D816V"], ["#12", "53/M", "SM", "Y", "N", "Y", "5.5", "D816V/M541L"], ["#13", "35/F", "SM", "Y", "Y", "Y", "44.7", ""], ["#14", "22/F", "CM", "", "N", "N", "5.0", ""], ["#15", "38/F", "SM", "Y", "Y", "Y", "7.7", "D816V"], ["#16", "52/M", "SM", "Y", "N", "Y", "37.5", "D816V"], ["#17", "46/F", "CM", "", "Y", "Y", "4.5", ""], ["#18", "55/M", "SM", "", "Y", "Y", "27.1", "D816V"], ["#19", "48/M", "SM", "Y", "N", "Y", "16.2", ""], ["#20", "32/M", "SM", "Y", "N", "Y", "53.5", "D816V"], ["#21", "44/F", "SM", "", "N", "N", "16.0", ""], ["#22", "60/F", "SM", "Y", "N", "Y", "23.6", ""], ["#23", "62/F", "SM", "", "N", "N", "80.4", "D816V"], ["#24", "49/M", "SM", "Y", "N", "Y", "29.1", "D816V"], ["#25", "49/F", "SM", "Y", "N", "Y", "37.4", ""], ["#26", "35/F", "SM", "Y", "Y", "Y", "16.5", ""], ["#27", "67/F", "CM", "", "N", "N", "7.2", ""], ["#28", "38/F", "SM", "Y", "Y", "Y", "26.2", "D816V"], ["#29", "57/M", "SM", "Y", "Y", "Y", "77.4", "D816V"], ["#30", "32/M", "SM", "Y", "Y", "Y", "40.8", "D816V"], ["#31", "39/M", "CM", "", "Y", "Y", "8.8", ""], ["#35", "34/M", "SM", "Y", "Y", "Y", "28.7", ""], ["#36", "52/F", "SM", "Y", "N", "Y", "16.1", "D816V"], ["#37", "28/F", "CM", "", "N", "N", "7.7", ""], ["#43", "71/F", "SM", "", "N", "N", "9.7", ""], ["#45", "23/M", "CM", "", "N", "N", "4.3", ""], ["#46", "75/F", "SM", "", "N", "N", "18.2", ""], ["#47", "46/F", "SM", "Y", "Y", "Y", "7.3", ""], ["#51", "29/M", "SM", "Y", "N", "Y", "64.5", ""], ["#52", "44/M", "SM", "Y", "N", "Y", "7.41", "D816V"], ["#58", "38/M", "SM", "Y", "N", "Y", "26.3", ""], ["#59", "67/F", "SM", "Y", "Y", "Y", "30.6", ""], ["#60", "49/F", "SM", "Y", "N", "Y", "15.8", "D816V"], ["#63", "56/M", "SM", "Y", "N", "Y", "60.8", "D816V"], ["#64", "24/M", "SM", "Y", "Y", "Y", "11.4", "D816V"], ["#66", "36/F", "SM", "Y", "N", "Y", "6.6", "D816V"]], "row_count": 42, "column_count": 8, "numeric_cells": 141, "header_rows": 1, "locator": "section[4]/table-wrap[1]#tbl1"}}, {"id": "asset:table:pmid:32575983:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:7cf7cebad78ccb7a0832cb07abdd0ce9f2eae73cad59748719bad2c60bd423e8", "bytes": 11835, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[6]/table-wrap[1]#tbl2", "version": null, "note": "UniProt-KB Code, Experimental and Theoretical Average Mass Values ± Standard Deviations (SD), Average (Mav) and Monoisotopic ([M + H]+), Elution Times of Proteins and Peptides Analyzed, and Their PTMsb", "structure": {"pmcid": "PMC8008451", "section_index": 6, "section_title": "RP-HPLC-Low-Resolution ESI-MS Analysis", "row_count": 64, "column_count": 7}, "table": {"label": "Table 2", "caption": "UniProt-KB Code, Experimental and Theoretical Average Mass Values ± Standard Deviations (SD), Average (Mav) and Monoisotopic ([M + H]+), Elution Times of Proteins and Peptides Analyzed, and Their PTMsb", "rows": [["proteins/peptides", "el. time (min ± 0.5)", "Mav ± SD exper. (theor)", "m/z (charge) for XIC search", "[M + H]+ ± SD exper. (theor)", "PTMs", "m/z (charge) for MS/MS"], ["Acid proline-rich proteins (PRP-1 and PRP-3 types)a"], ["PRP-1 (P02810)", "22.2", "15515 ± 2 (15514–15,515)", "1293.9(+12), 1194.4(+13), 1035.3(+15), 970.7(+16), 913.6(+17)", "15506.1 ± 0.1 (15506.24–15507.22)", "Q1 pyroglutamination, S8 and S22 phosphorylation", "1293.68(+12); 1194(+13); 1035.28 (+15); 970.58 (+16); 862.85(+18)"], ["PRP-1 1P", "22.9", "15435 ± 2 (15434–15,435)", "1287.2(+12), 1188.3(+13), 1030.0(+15), 965.7(+16), 908.9(+17)", "15426.1 ± 0.1 (15426.27–15427.26)", "Q1 pyroglutamination, S8 or S22 phosphorylation", "1287.01(+12); 1188.3(+13); 1030.0 (+15)"], ["PRP-1 0P", "23.2", "15355 ± 2 (15354–15,355)", "1280.5(+12), 1182.1(+13), 1024.6(+15), 960.7(+16), 904.2(+17)", "15346.1 ± 0.1 (15346.31–15347.29)", "Q1 pyroglutamination", "1534.42 (+10); 904.08 (+17)"], ["PRP-1 3P", "21.6", "15595 ± 2 (15594–15,595)", "1418.7(+11), 1300.5(+12), 1200.6(+13), 1040.6(+15), 975.7(+16)", "15585.8 ± 0.1 (15586.21–15587.19)", "Q1 pyroglutamination, S8, S17, and S22 phosphorylation", "1733.70 (+9); 1560.08 (+10); 1114.61 (+14); 975.56 (+16)"], ["PRP-3 (P02810)", "22.8", "11161 ± 1 (11161–11,162)", "1595.5(+7), 1396.2(+8), 1015.7(+11), 931.1(+12), 859.6(+13)", "11155.01 ± 0.07 (11156.08–11157.06)", "Q1 pyroglutamination, S8 and S22 phosphorylation", "931.09(+12); 798.07(+14); 745.00(+15)"], ["PRP-3 1P", "23.4", "11081 ± 1 (11081–11,082)", "1584.1(+7), 1386.2(+8), 1008.4(+11), 924.5(+12), 853.4(+13)", "11075.98 ± 0.07 (11076.11–11077.09)", "Q1 pyroglutamination, S8 or S22 monophosphorylation", "1386.13(+8); 1008.28(+11); 853.31(+13)"], ["PRP-3 0P", "23.8", "11001 ± 1 (11001–11,002)", "1376.2(+8), 1101.2(+10), 917.8(+12) 786.8(+14)", "10996.01 ± 0.07 (10996.14–10997.13)", "Q1 pyroglutamination", "1001.10(+11); 786.72(+14)"], ["PRP-3 desR6", "22.8", "11004 ± 1 (11005–11,006)", "1573.2(+7), 1223.8(+9), 1001.5(+11), 847.6(+13)", "10999.85 ± 0.07 (10999.97–11000.96)", "C-term. R106 removal from PRP-3", "1001.45(+11); 918.08(+12)"], ["P-C peptide (P02810)", "15.0", "4370.9 ± 0.4 (4370.8)", "1457.9(+3), 1093.7(+4)", "4369.19 ± 0.03 (4369.20)", "", "1457.07(+3); 1093.05(+4); 874.64(+5); 729.04(+6)"], ["Statherin"], ["statherin (P02808)", "29.2", "5380.0 ± 0.5 (5379.7)", "1794.2(+3), 1345.9(+4), 1076.9(+5)", "5377.46 ± 0.03 (5377.45)", "S2 and S3 phosphorylation", "1793.17(+3); 1345.12(+4); 1076.30(+5)"], ["statherin 1P", "28.9", "5299.9 ± 0.5 (5299.7)", "1767.6(+3), 1325.9(+4), 1060.9(+5)", "5297.46 ± 0.03 (5297.48)", "S2 or S3 phosphorylation", "1325.12(+4); 1060.30(+5)"], ["statherin des-F43", "27.8", "5232.4 ± 0.5 (5232.5)", "1745.1(+3), 1309.1(+4), 1047.5(+5)", "5230.39 ± 0.03 (5230.38)", "C-term. F43 removal from statherin", "1744.13(+3); 1308.35(+4); 1046.88(+5)"], ["statherin desT42-F43", "27.9", "5131.2 ± 0.5 (5131.4)", "1711.4(+3), 1283.8(+4), 1027.2(+5)", "5129.34 ± 0.03 (5129.33)", "C-term. T42 and F43 removal from statherin", "1710.45(+3); 1283.09(+4); 1026.67(+5)"], ["statherin desD1", "28.7", "5264.7 ± 0.5 (5264.6)", "1755.9(+3), 1317.2(+4), 1053.9(+5)", "5262.43 ± 0.03 (5262.42)", "N-term D1 removal from statherin", "1754.81(+3); 1316.36(+4); 1053.29(+5)"], ["statherin des1-9", "28.5", "4127.9 ± 0.4 (4127.6)", "1376.9(+3), 1032.9(+4)", "4126.00 ± 0.02 (4125.99)", "removal of D1SSEEKFLR9 from statherin", "1376.00(+3); 1032.25(+4)"], ["statherin des1-10", "28.0", "3971.3 ± 0.4 (3971.4)", "1986.7(+2), 1324.8(+3)", "3969.88 ± 0.02 (3969.89)", "Removal of D1SSEEKFLRR10 from statherin", "1323.96(+3); 993.22(+4)"], ["statherin des1-13", "27.5", "3645.2 ± 0.4 (3645.0)", "1823.6(+2), 1216.1(+3)", "3643.69 ± 0.02 (3643.68)", "Removal of D1SSEEKFLRRIGR13 from statherin", "1215.23(+3); 911.68(+4)"], ["P-B peptide"], ["P-B peptide (P02814)", "30.0", "5792.9 ± 0.5 (5792.7)", "1932.0(+3), 1449.2(+4), 1159.6(+5)", "5790.05 ± 0.04 (5790.04)", "", "1930.68(+3); 1448.27(+4); 1158.82(+5)"], ["P-B des1-4", "30.0", "5371.0 ± 0.5 (5371.3)", "1791.4(+3), 1343.8(+4), 1075.3(+5)", "5368.83 ± 0.03 (5368.82)", "removal of Q1RGP4 from P-B", "1790.25(+3); 1342.96(+4); 1074.57(+5)"], ["P-B des1-5", "30.3", "5215.0 ± 0.5 (5215.1)", "1739.4(+3), 1304.8(+4), 1044.0(+5)", "5212.74 ± 0.03 (5212.73)", "removal of Q1RGPR5 from P-B", "1303.93(+4); 1043.35(+5)"], ["P-B des1-7", "30.1", "5060.1 ± 0.5 (5060.9)", "1688.0(+3), 1266.2(+4), 1013.2(+5)", "5058.66 ± 0.03 (5058.65)", "removal of Q1RGPRGP7 from P-B", "1686.88(+3); 1265.42(+4); 1012.54(+5)"], ["P-B des1-12", "27.5", "4549.0 ± 0.5 (4549.3)", "1517.5(+3), 1138.3(+4)", "4547.41 ± 0.02 (4547.41)", "removal of Q1RGPRGPYPPGP12 from P-B", "1137.61(+4)"], ["Histatins"], ["Hst-1 (P15515)", "21.9", "4928.2 ± 0.5 (4928.2)", "1644.1(+3), 1233.5(+4)", "4926.19 ± 0.03 (4926.20)", "S2 phosphorylation", "986.05(+5); 821.87(+6); 704.61(+7)"], ["Hst-1 0P", "22.0", "4848.2 ± 0.5 (4848.2)", "1617.4(+3), 1213.5(+4)", "4846.24 ± 0.03 (4846.23)", "", "970.05(+5)"], ["Hst-3 (P15516)", "17.7", "4062.2 ± 0.4 (4062.4)", "1355.1(+3), 1016.6(+4)", "4060.97 ± 0.02 (4060.98)", "", "1015.99(+4); 813.00(+5); 677.67(+6)"], ["Hst-3 1/25", "14.3", "3192.4 ± 0.3 (3192.5)", "1065.1(+3), 799.1(+4)", "3191.63 ± 0.02 (3191.62)", "removal of S26NYLYDN32 from Hst-3", "400.09(+8); 456.95(+9)"], ["Hst-3 1/24", "14.6", "3036.5 ± 0.3 (3036.3)", "1013.2(+3), 760.1(+4)", "3035.53 ± 0.02 (3035.52)", "removal of S26NYLYD31 from Hst-3", "608.11(+5); 506.93(+6); 434.65(+7)"], ["Cystatins"], ["cystatin A (P01040)", "31.8", "11005 ± 2 (11006.5)", "1001.59(+11), 1101.59(+10), 1223.94(+9), 1376.81(+8), 1573.36(+7), 1835.42(+6)", "11000.65 ± 0.07 (11000.67)", "", "1376.83(+8); 847.74(+13); 787.19(+14); 734.85(+15);"], ["cystatin A Nα-Ac", "33", "11047 ± 2 (11048.5)", "1005.41(+11), 1105.85(+10), 1228.61(+9), 1382.06(+8), 1579.36(+7), 1842.42(+6)", "11042.55 ± 0.07 (11042.68)", "N-terminal acetylation", "1381.79(+8); 789.98(+14)"], ["cystatin B-SSG (P04080)", "32.8", "11486 ± 2 (11486.9)", "1915.5(+6), 1642.0(+7), 1436.9(+8), 1277.3(+9), 1149.7(+10), 1045.3(+11)", "11480.61 ± 0.07 (11480.68)", "N-terminal acetylation, C3 glutathionylation", "1436.72(+8); 1277.31(+9); 766.91(+15), 718.79(+16)"], ["cystatin C (P01034)", "35.1", "13342 ± 2 (13343.1)", "1483.57(+9), 1335.32(+10), 1214.02(+11), 1112.93(+12), 1027.40(+13)", "13335.31 ± 0.08 (13335.58)", "2 disulfide bridges", "1112.81(+12); 890.50(+15)"], ["cystatin C Mox", "35.3", "13358 ± 1 (13358.4)", "1485.28(+9), 1336.85(+10), 1215.41(+11), 1114.21(+12), 1028.58(+13)", "13351.60 ± 0.08 (13351.57)", "M14 oxidation of cystatin C", "1114.23(+12); 954.20(+14)"], ["cystatin D-R26 des1-8 (P28325)", "38.0", "13163 ± 2 (13163.0)", "1646.40 (+8), 1463.60 (+9), 1317.30 (+10), 1197.60 (+11), 1097.90 (+12), 1013.50 (+13)", "13155.25 ± 0.08 (13155.48)", "removal of G1SASAQSR8, 2 disulfide bridges", "941.09(+14); 823.71(+16)"], ["cystatin D-R26 des1-5", "37.7", "13517 ± 2 (13517.3)", "1690.70(+8), 1502.90(+9), 1352.70 (+10), 1229.80 (+11), 1127.4 (+12), 1040.40 (+13)", "13509.41 ± 0.08 (13509.65)", "Q1 pyroglutamination after removal of G1SASA5, 2 disulfide bridges", "1502.63(+9), 1040.87(+13) 966.48(+14); 845.72(+16)"], ["cystatin S (P01036)", "35.3", "14186 ± 2 (14185)", "1774.3(+8), 1577.2(+9), 1419.6(+10), 1290.6(+11), 1183.2(+12), 1092.2(+13), 1014.3(+14)", "14176.61 ± 0.08 (14176.81)", "2 disulfide bridges", "946.58(+15); 835.22(+17)"], ["cystatin S1", "35.3", "14266 ± 2 (14265)", "1784.3(+8), 1586.1(+9), 1427.6(+10), 1297.9(+11), 1189.8(+12), 1098.4(+13), 1020.0(+14)", "14256.66 ± 0.09 (14256.77)", "S3 phosphorylation of cystatin S, 2 disulfide bridges", "1098.37(+13); 1019.69(+14); 951.91(+15)"], ["cystatin S1ox", "35.3", "14281 ± 2 (14280.7)", "1786.40(+8), 1589.70 (+9), 1429.30 (+10), 1299.50 (+11), 1191.30 (+12), 1099.70 (+13)", "14272.66 ± 0.09 (14272.77)", "W23 oxidation of cystatin S1", "1299.08(+11); 1099.36(+13); 894.67(+16)"], ["cystatin S2", "35.3", "14346 ± 2 (14345)", "1794.3(+8), 1595.0(+9), 1435.6(+10), 1305.2(+11), 1196.5(+12), 1104.5(+13), 1025.7(+14)", "14336.58 ± 0.09 (14336.74)", "S1 and S3 phosphorylation of cystatin S, 2 disulfide bridges", "957.31(+15); 897.55(+16)"], ["cystatin SN (P01037)", "34.6", "14312 ± 2 (14313)", "1790.0(+8), 1591.2(+9), 1432.2(+10), 1302.1(+11), 1193.7(+12), 1101.9(+13), 1023.3(+14)", "14304.03 ± 0.09 (14304.09)", "2 disulfide bridges", "1023.29(+14); 796.01(+18); 716.50(+20)"], ["cystatin SNox", "34.6", "14328 ± 2 (14328)", "1792.30(+8), 1593.20 (+9), 1434.00 (+10), 1303.30 (+11), 1195.20 (+12), 1103.30 (+13)", "14320.09 ± 0.09 (14319.84)", "2 disulfide bridges, W23 oxidation", "843.64(+17); 754.26(+19); 717.35(+20); 682.52(+21)"], ["cystatin SA (P09228)", "36.8", "14347 ± 2 (14346)", "1794.4(+8), 1595.1(+9), 1435.7(+10), 1305.3(+11), 1196.6(+12), 1104.6(+13), 1025.8(+14)", "14337.87 ± 0.09 (14338.01)", "1 disulfide bridge", "897.50(+16); 844.88(+17); 798.78(+18);"], ["Antileukoproteinase"], ["SLPI (P03973)", "26.2", "11709 ± 1 (11710)", "1952.64(+6), 1673.84(+7), 1464.73(+8), 1302.10(+9)", "11702.41 ± 0.07 (11702.36)", "8 disulfide bridges", "1171.82(+10); 1065.47(+11); 976.69(+12); 837.45(+14)"], ["α-Defensins"], ["α-defensin 1 (P59665)", "23.5", "3442.5 ± 0.3 (3442.1)", "1772.03(+2), 1148.36(+3), 861.52(+4)", "3440.45 ± 0.02 (3440.519)", "3 disulfide bridges", "861.14(+4); 689.11(+5)"], ["α-defensin 2 (P59665/6)", "23.5", "3370.7 ± 0.3 (3370.9)", "1686.49(+2), 1124.66(+3), 843.75(+4)", "3370.41 ± 0.02 (3370.484)", "3 disulfide bridges", "843.61(+4); 675.10(+5)"], ["α-defensin 3 (P59666)", "23.5", "3485.8 ± 0.3 (3486.1)", "1744.03(+2), 1163.03(+3), 872.52(+4)", "3484.53 ± 0.02 (3484.509)", "3 disulfide bridges", "872.11(+4); 698.09(+5)"], ["α-defensin 4 (P12838)", "27.2", "3709.1 ± 0.3 (3709.4)", "1855.71(+2), 1237.48(+3), 928.36(+4)", "3707.68 ± 0.02 (3707.767)", "3 disulfide bridges", "928.18(+4); 742.74(+5);"], ["Thymosin β4"], ["Tβ4 (P62328)", "18.5", "4963.7 ± 0.5 (4963.5)", "1655.51(+3), 1241.88(+4), 993.71(+5)", "4961.47 ± 0.03 (4961.494)", "N-terminal acetylation", "710.08(+7), 621.32(+8)"], ["S100A proteins"], ["S100A8 (P05109)", "40.4", "10834 ± 2 (10834.6)", "1355.3(+8), 1204.8(+9), 1084.5(+10), 985.9(+11)", "10827.41 ± 0.07 (10828.66)", "", "903.62(+12); 834.11(+13); 774.75(+14)"], ["S100A8 SNO", "40.8", "10863 ± 2 (10863.5)", "1358.9(+8), 1208.1(+9), 1087.3(+10), 988.6(+11)", "10857.37 ± 0.07 (10857.65)", "C42 nitrosylation", "1087.49(+10); 680.03(+16); 640.03(+17)"], ["S100A8 hyperoxidized", "39.3", "10915 ± 2 (10914.6)", "1365.3(+8), 1213.7(+9), 1092.5(+10), 993.2(+11)", "10908.40 ± 0.07 (10908.63)", "C42-SO3H, W54 dioxidation or C42-SO3H, W54, and M78 oxidation", "993.20(+11); 910.37(+12); 683.16(+16); 642.85(+17)"], ["S100A9(S) (P06702)", "42.2", "12690 ± 2 (12689.3)", "1410.9(+9), 1269.9(+10), 1154.6(+11), 1058.4(+12), 977.1(+13)", "12682.21 ± 0.08 (12682.29)", "N-term. Acetylation after M1TCKM5 removal", "1410.67(+9); 1269.93(+10); 977.22(+13); 793.95(+16); 747.48(+17); 705.85(+18);"], ["S100A9(S) 1P", "42.2", "12770 ± 2 (12769.3)", "1419.8(+9), 1277.9(+10), 1161.8(+11), 1065.1(+12), 983.3(+13)", "12762.05 ± 0.08 (12762.26)", "T108 phosphorylation of S100A9(S)", "1161.66(+11); 798.96(+16); 710.29(+18)"], ["S100A9(S)ox", "41.3", "12706 ± 2 (12705.3)", "1412.7(+9), 1271.5(+10), 1156.0(+11), 1059.8(+12), 978.3(+13)", "12698.14 ± 0.08 (12698.29)", "M89, or 78 or 76 or 58 oxidation of S100A9(S)", "1271.41(+10); 1155.92(+11); 908.51(+14)"], ["S100A9(S)ox 1P", "41.3", "12786 ± 2 (12785.3)", "1421.9(+9), 1279.5(+10), 1163.3(+11), 1066.4(+12), 984.5(+13)", "12778.21 ± 0.08 (12778.25)", "T108 phosphorylation of S100A9(S)ox", "1419.82(+9); 983.26(+13); 913.10(+14)"]], "row_count": 64, "column_count": 7, "numeric_cells": 355, "header_rows": 1, "locator": "section[6]/table-wrap[1]#tbl2"}}, {"id": "asset:table:pmid:32575983:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:abf58967b1d8178cc9fd9ab79bd07f8993cdb2d176bd48ae907ef9ecef227df1", "bytes": 5282, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#tbl3", "version": null, "note": "XIC Peak Areas Values (Mean ± SD), Frequencies, and p Values Obtained by Statistical Analysis by Comparing the Three Patients’ Groups with Respect to the Controls and Each Othera", "structure": {"pmcid": "PMC8008451", "section_index": 10, "section_title": "Quantitative Comparison between Controls and Patients", "row_count": 49, "column_count": 7}, "table": {"label": "Table 3", "caption": "XIC Peak Areas Values (Mean ± SD), Frequencies, and p Values Obtained by Statistical Analysis by Comparing the Three Patients’ Groups with Respect to the Controls and Each Othera", "rows": [["", "", "XIC peak area ×108 (mean ± SD) and frequency", "p values"], ["no.", "protein/peptide", "CM", "SM", "Ctrls", "CM vs Ctrls", "SM vs Ctrls"], ["#1", "PRP-1", "17.8 ± 10.1 (6/6)", "27.4 ± 27.2 (35/35)", "99.9 ± 70.9 (48/48)", "<0.0001 ↓CM", "< 0.0001 ↓SM"], ["#2", "PRP-1 1P", "2.5 ± 3.1 (5/6)", "3.7 ± 5.2 (29/35)", "12.8 ± 12.9 (47/48)", "0.002 ↓CM", "< 0.0001 ↓SM"], ["#3", "PRP-1 0P", "(0/6)", "0.09 ± 0.3 (6/35)", "0.5 ± 0.9 (22/48)", "NA", "0.003 ↓SM"], ["#4", "PRP-1 3P", "0.2 ± 0.2 (4/6)", "0.4 ± 0.6 (22/35)", "2.0 ± 1.9 (44/48)", "0.002 ↓CM", "< 0.0001 ↓SM"], ["#5", "PRP-3", "5.9 ± 4.4 (6/6)", "9.5 ± 11.3 (33/35)", "35.1 ± 29.3 (48/48)", "0.0002 ↓CM", "< 0.0001 ↓SM"], ["#6", "PRP-3 1P", "1.1 ± 1.0 (6/6)", "1.5 ± 1.8 (29/35)", "4.9 ± 4.1 (47/48)", "0.002 ↓CM", "< 0.0001 ↓SM"], ["#7", "PRP-3 0P", "(0/10)", "0.004 ± 0.02 (2/35)", "0.4 ± 1.1 (18/48)", "NA", "0.0003 ↓SM"], ["#8", "PRP-3 desR106", "3.1 ± 2.7 (6/6)", "2.8 ± 5.9 (26/35)", "3.8 ± 6.2 (40/48)", "•", "•"], ["#9", "P-C peptide", "4.1 ± 4.4 (6/6)", "7.0 ± 10.0 (33/35)", "20.4 ± 16.2 (48/48)", "0.001 ↓CM", "< 0.0001 ↓SM"], ["#10", "statherin", "5.4 ± 6.6 (5/6)", "6.0 ± 6.6 (34/35)", "13.4 ± 10.1 (47/47)", "0.02 ↓CM", "0.0001 ↓SM"], ["#11", "Stath. 1P", "0.2 ± 0.2 (3/6)", "0.1 ± 0.2 (17/35)", "0.3 ± 0.4 (32/47)", "•", "0.03 ↓SM"], ["#12", "Stath. des-F43", "1.1 ± 1.0 (6/6)", "1.0 ± 0.9 (34/35)", "1.9 ± 1.8 (46/47)", "•", "0.006 ↓SM"], ["#13", "Stath. desT42-F43", "0.7 ± 0.4 (6/6)", "0.4 ± 0.4 (25/35)", "0.7 ± 0.7 (46/47)", "•", "•"], ["#14", "Stath. desD1", "0.7 ± 0.9 (5/6)", "0.5 ± 0.5 (31/35)", "0.8 ± 0.8 (46/47)", "•", "0.02 ↓SM"], ["#15", "Stath. des1-9", "0.1 ± 0.2 (5/6)", "0.2 ± 0.4 (18/35)", "0.7 ± 0.7 (40/47)", "•", "< 0.0001 ↓SM"], ["#16", "Stath. des1-10", "0.2 ± 0.2 (5/6)", "0.3 ± 0.4 (24/35)", "0.5 ± 0.5 (44/47)", "•", "0.001 ↓SM"], ["#17", "Stath. des1-13", "0.1 ± 0.1 (4/6)", "0.1 ± 0.2 (22/35)", "0.3 ± 0.2 (45/47)", "0.04 ↓CM", "< 0.0001 ↓SM"], ["#18", "P-B peptide", "7.6 ± 7.9 (6/6)", "9.2 ± 7.8 (34/35)", "21.9 ± 14.3 (47/47)", "0.004 ↓CM", "< 0.0001 ↓SM"], ["#19", "P-B des1-4", "0.9 ± 0.6 (6/6)", "1.0 ± 0.8 (31/35)", "1.5 ± 1.7 (39/48)", "•", "•"], ["#20", "P-B des1-5", "3.0 ± 3.6 (6/6)", "1.8 ± 2.4 (30/35)", "2.3 ± 2.8 (42/48)", "•", "•"], ["#21", "P-B des1-7", "1.7 ± 0.9 (6/6)", "1.7 ± 1.5 (32/35)", "4.4 ± 2.8 (47/48)", "0.007 ↓CM", "< 0.0001 ↓SM"], ["#22", "P-B des1-12", "0.8 ± 0.4 (6/6)", "0.6 ± 0.6 (31/35)", "1.0 ± 1.4 (46/48)", "•", "•"], ["#23", "Hst-1", "1.1 ± 1.6 (4/6)", "1.1 ± 1.5 (24/35)", "2.9 ± 2.9 (34/48)", "•", "0.02 ↓SM"], ["#24", "Hst-1 0P", "(0/6)", "0.2 ± 0.3 (15/35)", "0.4 ± 0.7 (23/48)", "NA", "•"], ["#25", "Hst-3", "0.01 ± 0.03 (1/6)", "0.3 ± 0.6 (12/35)", "1.2 ± 1.7 (26/48)", "NA", "0.008 ↓SM"], ["#26", "Hst-3 1/25", "(0/6)", "0.04 ± 0.1 (6/35)", "0.9 ± 1.2 (25/48)", "NA", "0.0001 ↓SM"], ["#27", "Hst-3 1/24", "(0/6)", "0.8 ± 1.7 (15/27)", "3.0 ± 3.4 (40/48)", "NA", "< 0.0001 ↓SM"], ["#28", "Cyst. A", "2.0 ± 1.4 (6/6)", "1.2 ± 1.2 (35/35)", "2.2 ± 1.9 (47/48)", "•", "0.001 ↓SM"], ["#29", "Cyst B (all proteoforms)", "1.3 ± 1.1 (6/6)", "1.2 ± 1.2 (34/35)", "1.4 ± 1.3 (43/48)", "•", "•"], ["#30", "Cyst. C (all proteoforms)", "0.03 ± 0.07 (1/6)", "0.05 ± 0.2 (3/35)", "0.6 ± 0.7 (32/48)", "NA", "< 0.0001 ↓SM"], ["#31", "Cyst. D-R26 des1-5", "0.4 ± 0.9 (1/6)", "0.5 ± 0.8 (19/35)", "0.8 ± 1.1 (28/48)", "NA", "•"], ["#32", "Cyst. D-R26 des1-8", "(0/6)", "0.06 ± 0.1 (11/35)", "0.1 ± 0.2 (15/48)", "NA", "•"], ["#33", "Cyst. S", "(0/6)", "0.3 ± 0.7 (11/35)", "2.5 ± 0.5 (29/48)", "NA", "0.0007 ↓SM"], ["#34", "Cyst. S1 (all proteoforms)", "11.3 ± 12.7 (6/6)", "4.5 ± 3.8 (33/35)", "10.3 ± 10.6 (45/48)", "•", "0.002 ↓SM"], ["#35", "Cyst. S2", "1.9 ± 3.0 (2/6)", "2.2 ± 3.6 (22/35)", "3.8 ± 3.9 (45/48)", "•", "0.002 ↓SM"], ["#36", "Cyst. SN (all proteoforms)", "10.2 ± 13.8 (4/6)", "9.2 ± 11.1 (31/35)", "20.7 ± 17.1 (47/48)", "•", "0.0005 ↓SM"], ["#37", "Cyst. SA", "0.9 ± 1.9 (2/6)", "0.8 ± 2.1 (9/35)", "2.9 ± 3.8 (35/48)", "•", "<0.0001 ↓SM"], ["#38", "Tβ4", "0.4 ± 0.3 (5/6)", "0.4 ± 0.5 (24/35)", "0.8 ± 1.0 (30/48)", "•", "•"], ["#39", "α-defensin 1", "1.1 ± 0.7 (6/6)", "1.4 ± 1.9 (33/35)", "1.9 ± 2.9 (41/48)", "•", "•"], ["#40", "α-defensin 2", "0.8 ± 0.6 (6/6)", "0.7 ± 0.9 (31/35)", "1.3 ± 1.7 (37/48)", "•", "•"], ["#41", "α-defensin 3", "0.6 ± 0.7 (5/6)", "0.3 ± 0.4 (21/35)", "0.8 ± 1.3 (30/48)", "•", "•"], ["#42", "α-defensin 4", "0.2 ± 0.1 (3/6)", "0.1 ± 0.2 (15/35)", "0.3 ± 0.4 (23/48)", "•", "•"], ["#43", "S100A9(S) + (S)ox", "1.3 ± 1.5 (4/6)", "1.5 ± 1.9 (24/35)", "2.3 ± 2.7 (39/48)", "•", "•"], ["#44", "S100A9(S) 1P + (S)ox 1P", "0.4 ± 0.5 (3/6)", "0.6 ± 1.0 (16/35)", "0.5 ± 1.0 (17/48)", "•", "•"], ["#45", "SLPI", "0.2 ± 0.3 (3/6)", "0.2 ± 0.8 (18/35)", "0.1 ± 0.20 (10/48)", "•", "0.005 ↑SM"], ["#46", "S100A8 (all proteoforms)", "0.5 ± 1.1 (1/6)", "0.6 ± 1.1 (14/35)", "0.2 ± 0.6 (9/48)", "NA", "0.02 ↑SM"], ["#47", "S100A8-SNO", "0.5 ± 1.1 (1/6)", "0.3 ± 0.7 (8/35)", "0.1 ± 0.5 (6/48)", "NA", "•"]], "row_count": 49, "column_count": 7, "numeric_cells": 263, "header_rows": 2, "locator": "section[10]/table-wrap[1]#tbl3"}}, {"id": "asset:table:pmid:32575983:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:a1905f171d1bc6d3b40026923a10bf24cb17ef2c110aed3852a417f46b60af36", "bytes": 1053, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#tbl4", "version": null, "note": "Results of Correlation Analysis between Salivary Proteins/Peptides and Tryptase Levels in SM Patients and in the Subgroup SM-Ca", "structure": {"pmcid": "PMC8008451", "section_index": 12, "section_title": "Correlation Analysis with Tryptase and with Oral Aphtosis and GI Symptoms", "row_count": 14, "column_count": 6}, "table": {"label": "Table 4", "caption": "Results of Correlation Analysis between Salivary Proteins/Peptides and Tryptase Levels in SM Patients and in the Subgroup SM-Ca", "rows": [["", "SM (n = 35)", "SM-C (n = 8)", ""], ["protein/peptide", "p value", "R", "p value", "R", "distinctive between SM-C and SM+C"], ["PRP-1 1P", "", "", "0.04 (+)", "0.77", ""], ["PRP-3 1P", "", "", "0.03 (+)", "0.77", ""], ["PRP-3 desR106", "", "", "0.007 (+)", "0.88", "Y (↑ in SM-C)"], ["Statherin desD1", "", "", "0.01 (+)", "0.86", ""], ["Statherin des1-10", "0.03 (+)", "0.40", "0.02 (+)", "0.79", ""], ["Statherin des1-13", "0.02 (+)", "0.40", "0.02 (+)", "0.79", ""], ["P-B des1-4", "0.02 (+)", "0.38", "0.002 (+)", "0.93", ""], ["P-B des1-5", "", "", "0.02 (+)", "0.81", "Y (↑ in SM-C)"], ["P-B des1-7", "", "", "0.01 (+)", "0.86", ""], ["P-B des1-12", "", "", "0.006 (+)", "0.89", ""], ["Cystatin D-R26 des1-5", "0.02 (+)", "0.40", "0.005 (+)", "0.90", "Y (↑ in SM-C)"], ["Thymosin β4", "", "", "0.005 (−)", "–0.84", "Y (↓ in SM-C)"]], "row_count": 14, "column_count": 6, "numeric_cells": 45, "header_rows": 2, "locator": "section[12]/table-wrap[1]#tbl4"}}], "gaps": ["asset:data:geo:PXD017759 not downloaded", "asset:data:geo:PXD017759 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "welch_t_test", "label": "Group comparison", "dsl_operations": ["welch_t"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "reordered", "quote": "The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous). Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05."}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["welch_t"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: welch_t_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD017759"], "resolved_accessions": ["PXD017759"], "statements": ["Data are available via ProteomeXchange with identifier PXD017759."], "basis": "The paper names PXD017759 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["welch_t"], "assets": ["source:pmid:32575983", "data:geo:PXD017759", "asset:table:pmid:32575983:1", "asset:table:pmid:32575983:2", "asset:table:pmid:32575983:3", "asset:table:pmid:32575983:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD017759"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:20:34Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 44102, "completion_tokens": 1156, "cached_tokens": 784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32575983", "type": "paper", "label": "pmid:32575983"}, {"id": "source:pmid:32575983", "type": "manuscript", "label": "PMID 32575983 full text"}, {"id": "data:geo:PXD017759", "type": "dataset", "label": "GEO PXD017759"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32575983", "type": "paper", "label": "pmid:32575983"}, {"id": "source:pmid:32575983", "type": "manuscript", "label": "PMID 32575983 full text"}, {"id": "data:geo:PXD017759", "type": "dataset", "label": "GEO PXD017759"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32575983", "type": "extraction", "used": ["source:pmid:32575983"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD017759", "type": "accession_resolution", "used": ["data:geo:PXD017759"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32575983", "parent_hash": "sha256:a7019602b245c7fa0a5763f9973d9d96a4ac082d1a5a9398e9a5df412a9ca938", "fork_of": null, "generation": 5}, "gaps": ["asset:data:geo:PXD017759 licence not read", "asset:data:geo:PXD017759 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["welch_t"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["The comparisons between the three groups of patients and that of the controls and between the three groups of patients have been performed with Mann–Whitney and Welch-corrected t tests, depending on the distribution (skewed or normal) and the variance (unequal or homogeneous). Correlation analyses, between the XIC peak area of the proteins/peptides under analysis and the tryptase levels of each patient, were performed with the Spearman test and considered significant when the p value was <0.05."], "order_basis": "analysis_only", "id": "assay:1"}]}